Numerous studies have investigated the role of immune-mediated chronic inflammation on the pathophysiology of endometriosis14,15 and attempted to evaluate various anti-inflammatory drugs, including tumor necrosis factor-alpha TNFα inhibitors16–18 and cyclooxygenase-2 (Cox-2) inhibitors19–21, in endometriosis. This evidence concerns the gene PTGS2 and endometriosis.